Skip to content

Advances in Motion provides health care professionals with information about the latest breakthroughs, research and clinical advances from Massachusetts General Hospital.

Featured In Cardiovascular

A recent Massachusetts General Hospital study suggests that exercise nearly doubles cardiovascular benefits in individuals with anxiety or depression. Their findings support previous evidence that regular physical activity benefits heart health by activating parts of the brain that counteract stress.

Featured In Digestive Health

In this video, Robert Goldstone, MD, of the Division of General and Gastrointestinal Surgery at Massachusetts General Hospital, discusses how he tackles research questions that are not easily answered—preferring to review retrospective databases in order to generalize data for the entire community.

Featured In OB/GYN

Researchers at Mass General are studying the effects of SARS-CoV-2 infection and mRNA vaccines in pregnant and lactating individuals, as well as neonates.

Featured In Research and Innovation

A Phase 3 clinical trial conducted by Massachusetts General Hospital researchers and an international team of colleagues has led to the FDA's approval of an oral drug for treatment of adults with pyruvate kinase deficiency, a rare red blood cell disorder.

Featured In Neuroscience

Clinician-researchers at the Center for Precision Psychiatry at Massachusetts General Hospital with colleagues at Harvard University, Harvard Medical School and Boston Children's Hospital have developed an algorithm to improve the prediction of suicide risk in clinical settings.

The Latest Orthopaedic Advances

Rohan Bhimani, MD, MBA, Daniel Guss, MD, MBA, and colleagues in the Foot and Ankle Research and Innovation Laboratory at Massachusetts General Hospital found that, even in the presence of a Weber B lateral malleolar ankle fracture, weight-bearing CT is still able to distinguish a stable from an unstable syndesmosis.

Aditya V. Karhade, MD, MBA, Joseph H. Schwab, MD, MS, and colleagues found free-text discharge summary notes have the greatest utility in a natural language processing algorithm for predicting the risk of readmission after posterior lumbar fusion. Progress notes had the least utility.

Contributing Physicians

Orthopaedic Shoulder, Elbow and Hand Surgeon, Massachusetts General Hospital, Co-Chief, Shoulder Service & Program Director, Shoulder Surgery Fellowship, Professor of Orthopedic Surgery, Harvard Medical School

Bassem T. Elhassan, MD

Chief, Orthopaedic Spine Surgery, Director, Spine Oncology & Co-Director, Stephen L. Harris Chordoma Center, Associate Professor of Orthopaedic Surgery, Harvard Medical School

Advances Specialties

Geriatrics and Palliative Care

Improvement of coping strategies was a key mechanism of the benefits of integrated palliative care for patients with acute myeloid leukemia who were hospitalized for intensive chemotherapy, Ashley M. Nelson, PhD, and colleagues conclude based on a secondary analysis of a randomized controlled trial.


Researchers at Massachusetts General Hospital have identified some of the earliest brain changes associated with the risk to develop Alzheimer's disease by studying a kindred with the PSEN1 E280A gene mutation.


Marc D. Succi, MD, Ottavia Zattra, and colleagues warn oncologists to plan for a surge of new and more advanced cancer diagnoses in upcoming months and years because of suboptimal CT imaging during—and after—the peak of the COVID-19 pandemic.

Education & Training Opportunities

May 25, 2022 - July 13, 2022

The Massachusetts General Hospital Corrigan Minehan Heart Center prepares future health care professionals and trains providers in innovative therapies and care. As part of these efforts, the center hosts regular Grand Rounds presentations from thought leaders and researchers on important cardiology topics. Cardiology Grand Rounds is open to all healthcare professionals.

September 29, 2022 - October 1, 2022

The Minimally Invasive and Novel Therapeutics (MINT) In Foregut Disease continuing medical education (CME) event, taking place from September 29-October 1, 2022, seeks to equip clinicians with knowledge of the latest physiologic tools needed to diagnose and treat benign foregut disease, and to teach them how different treatment options fit within the paradigm of overall foregut disease.

Clinical Trials

In Neuroscience

The study involves multiple visits over 6 months. You will complete an 8-week stress reduction treatment that includes a medical device worn in the ear and attend MRI and PET scans. You will also complete daily migraine diaries online.

In Cardiovascular

We are seeking individuals who self-identify as having high stress to participate in a randomized study using a mindfulness-based, stress-reduction intervention and PET-MR imaging.